Phase I trial of peginterferon lambda-1a in volunteers
Latest Information Update: 17 Oct 2008
Price :
$35 *
At a glance
- Drugs Peginterferon lambda-1a (Primary)
- Indications Hepatitis C; Viral infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors ZymoGenetics
- 07 Nov 2007 Status changed to completed.
- 15 Feb 2007 New trial record.